Puretech reports results from phase 2 study of lyt-100-cov in post-acute “long” covid with respiratory complications

Boston--(business wire)--puretech reports results from phase 2 study of lyt-100-cov in post-acute “long” covid with respiratory complications

PRTC Ratings Summary

PRTC Quant Ranking